Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma

Clinical trial NCT01907308 · WITHDRAWN

Trial details

NCT number: NCT01907308
Sponsor: University of Colorado, Denver
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2014-02-01
Primary completion: 2014-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.